Stock Detail
LIGAND PHARMACEUTICALS INCORPORATED
Drug Manufacturers Other
LGND @ Yahoo Finance | LGND Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $11.14 | $11.51 | $-0.35 | -3.05% | 0.00 | $11.49 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $11.39 | $11.11 | 97,984 | 219.16M | 197,127 | 31.10 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 11.65 | 11.39 | 11.25 | 10.99 | 10.85 |
Stock Profile
Ligand Pharmaceuticals Incorporated, a biotech company, engages in the discovery and development of drugs in the United States. It has research and development collaborations with pharmaceutical companies, including GlaxoSmithKline; Wyeth; Pfizer, Inc.; and TAP Pharmaceutical Products, Inc. for the treatment of market indications, such as thrombocytopenia, osteoporosis, menopausal symptoms, and frailty. The company's partnered products include Eltrombopag, a small-molecule TPO mimetic for thrombocytopenia, which is in phase III clinical trials; bazedoxifene, a monotherapy for osteoporosis; Aprela, a combination of bazedoxifene with PREMARIN for osteoporosis prevention, and vasomotor symptoms of menopause; and lasofoxifene, for osteoporosis and vaginal atrophy, which is in phase III clinical trials. Ligand Pharmaceuticals Incorporated was founded in 1987 and is headquartered in San Diego, California.